Rivaroxaban and Malignant neoplasm progression - a phase IV clinical study of FDA data
Summary:
Malignant neoplasm progression is reported as a side effect among people who take Rivaroxaban (rivaroxaban), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Pantoprazole, and have Lung cancer - non-small cell.
The phase IV clinical study analyzes which people have Malignant neoplasm progression when taking Rivaroxaban. It is created by eHealthMe based on reports of 26,430 people who have side effects when taking Rivaroxaban from the FDA, and is updated regularly.
What is Rivaroxaban?
Rivaroxaban has active ingredients of rivaroxaban. It is often used in blood clots. eHealthMe is studying from 26,544 Rivaroxaban users. Check the latest studies of Rivaroxaban.
What is Malignant neoplasm progression?
Malignant neoplasm progression (cancer tumour came back) is found to be associated with 1,514 drugs and 1,634 conditions by eHealthMe. Check the latest studies of Malignant neoplasm progression.
26,430 people reported to have side effects when taking Rivaroxaban.
Among them, 110 people (0.42%) have Malignant neoplasm progression.
Among these 110 people:
How long have people been on Rivaroxaban when they have Malignant neoplasm progression? *
What is the gender of people who have Malignant neoplasm progression when taking Rivaroxaban? *
What is the age of people who have Malignant neoplasm progression when taking Rivaroxaban? *
What are other drugs people take besides Rivaroxaban? *
What are other side effects people have besides Malignant neoplasm progression? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Rivaroxaban and have Malignant neoplasm progression?
- Check whether Malignant neoplasm progression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Rivaroxaban:
- Rivaroxaban (26,544 reports)
Malignant neoplasm progression treatments and more:
- Malignant neoplasm progression (107,528 reports)
How severe was Malignant neoplasm progression and when was it recovered:
Expand to all the drugs that have ingredients of rivaroxaban:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Rivaroxaban:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Malignant neoplasm progression:
- Malignant neoplasm progression (1,514 drugs)
Browse all the conditions that are associated with Malignant neoplasm progression:
- Malignant neoplasm progression (1,634 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on rivaroxaban (the active ingredients of Rivaroxaban) and Rivaroxaban (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Prostate Cancer and Bradycardia - 26 seconds ago
- Could Advair Diskus 100/50 cause Change Of Bowel Habit? - 36 seconds ago
- Drug interactions of Meloxicam and Promethazine Dm - 58 seconds ago
- Could Cataflam cause Hypotension? - a minute ago
- Could Aveed cause Headache? - a minute ago
- Dry Skin and Nausea And Vomiting - a minute ago
- Drug interactions of Ursodiol and Letairis - 2 minutes ago
- Could Azelastine cause Postural Orthostatic Tachycardia Syndrome? - 2 minutes ago
- Drug interactions of Chantix and Haldol - 2 minutes ago
- Could Vitamin K cause Hyperglycemia? - 2 minutes ago